Lexicon Pharmaceuticals

red light stop light street traffic signal
Pharma

Lexicon gets final FDA rejection for diabetes prospect

The company already moved to cut its commercial sales force following several FDA setbacks in its efforts to introduce sotagliflozin in diabetes.
Zoey Becker Dec 23, 2024 11:20am
graphic of the brain and the electrical signals that make it up

Acadia nabs Lexicon alum as new commercial lead

Dec 9, 2024 9:26am
Graphic of a fork in the road with arrows pointing in either direction

Lexicon steps out of commercial space after FDA setbacks

Nov 22, 2024 11:46am
Small white blocks with black text that say Diabetes Type 1 in all caps surrounded by syringes containing a blue liquid th

FDA expert panel spurns Lexicon's approval bid in type 1 diabetes

Nov 1, 2024 11:24am
heart failure

Viatris lays out $25M to tackle marketing of Lexicon's Inpefa

Oct 17, 2024 10:17am
A series of dice with a bag on them illustrating cost cuts

In restructuring move, Lexicon to lay off 50% of field force

Aug 13, 2024 3:34pm